Search Results

Vericel Corporation today announced that it will report its first-quarter 2024 financial results on Wednesday, May 8, 2024.

Vericel Corporation reported financial results and business highlights for the first quarter ended March 31, 2024.

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference at 9:40 a.m. ET on Wednesday, May 29, 2024.

Vericel Corporation today announced that Nick Colangelo, President and CEO will present at the Canaccord Genuity Musculoskeletal Conference.

Vericel Corporation, a leader in advanced therapies for the sports medicine and severe burn care markets, announced that it will report its fourth-quarter and full-year 2023 financial results on Thursday, February 29, 2024.